Compounds > vidarabine
Page last updated: 2024-08-22

vidarabine and Body Weight

vidarabine has been researched along with Body Weight in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19906 (85.71)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Awan, FT; Clemmons, AB; DeRemer, DL; Evans, S1
Balis, ME; Dunzendorfer, U; Kleinert, E; Relyea, NM; Whitmore, WF1
Barsoum, NJ; DiFonzo, CJ; Gough, AW; Gracon, SI; Sturgess, JM1
McLean, SL; Park, NH; Pavan-Langston, D1
Albert, DM; McLean, SL; Park, NH; Pavan-Langston, D1
Caron, N; Kimball, AP; Lee, SH1
Adlard, BP; Dobbing, J; Sands, J1

Other Studies

7 other study(ies) available for vidarabine and Body Weight

ArticleYear
Busulfan dosing (Q6 or Q24) with adjusted or actual body weight, does it matter?
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2015, Volume: 21, Issue:6

    Topics: Administration, Intravenous; Adult; Aged; Antineoplastic Agents, Alkylating; Area Under Curve; Body Weight; Busulfan; Disease-Free Survival; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Vidarabine

2015
Antigrowth effect of some inhibitors of polyamine synthesis on transplantable prostate cancer.
    Oncology, 1983, Volume: 40, Issue:1

    Topics: Animals; Body Weight; Drug Therapy, Combination; Eflornithine; Guanidines; Male; Mitoguazone; Neoplasm Transplantation; Neoplasms, Experimental; Ornithine; Polyamines; Prostatic Neoplasms; Rats; Vidarabine

1983
Comparison of the neonatal toxicity of two antiviral agents: vidarabine phosphate and cytarabine.
    Toxicology and applied pharmacology, 1982, Volume: 66, Issue:1

    Topics: Animals; Animals, Newborn; Antiviral Agents; Body Weight; Brain; Cytarabine; Female; Gestational Age; Growth; Hair; Organ Size; Pregnancy; Rats; Sex Factors; Vidarabine

1982
Acylovir in oral and ganglionic herpes simplex virus infections.
    The Journal of infectious diseases, 1979, Volume: 140, Issue:5

    Topics: Animals; Antiviral Agents; Body Weight; Guanine; Herpes Labialis; Male; Mice; Rabbits; Stomatitis, Herpetic; Trigeminal Ganglion; Trigeminal Nerve; Vidarabine; Virus Replication

1979
Therapy of experimental herpes simplex encephalitis with aciclovir in mice.
    Antimicrobial agents and chemotherapy, 1979, Volume: 15, Issue:6

    Topics: Animals; Antiviral Agents; Body Weight; Brain; Encephalitis; Guanosine; Herpes Simplex; Male; Mice; Vidarabine

1979
Effects of 2'-deoxycoformycin, 9-beta-D-arabinofuranosyladenine 5'-phosphate, and 1-beta-D-arabinofuranosylcytosine triple combination therapy on intracerebral leukemia 1210.
    Cancer research, 1977, Volume: 37, Issue:9

    Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Antineoplastic Agents; Azepines; Body Weight; Brain; Brain Neoplasms; Cytarabine; Deoxyribonucleotides; Drug Synergism; Drug Therapy, Combination; Female; In Vitro Techniques; Kinetics; Leukemia L1210; Mice; Mice, Inbred DBA; Vidarabine

1977
A comparison of the effects of cytosine arabinoside and adenine arabinoside on some aspects of brain growth and development in the rat.
    British journal of pharmacology, 1975, Volume: 54, Issue:1

    Topics: Age Factors; Animals; Animals, Newborn; Body Weight; Brain; Cerebellum; Cytarabine; Discrimination Learning; Dose-Response Relationship, Drug; Female; Injections, Intraperitoneal; Maternal-Fetal Exchange; Pregnancy; Purine Nucleosides; Rats; Vidarabine

1975